Cosmo NV (CMOPF)
69.50
+1.00
(+1.46%)
USD |
OTCM |
Sep 01, 16:00
Cosmo Research and Development Expense (TTM) : 36.52M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.52M |
| December 31, 2025 | 38.52M |
| June 30, 2025 | 51.16M |
| December 31, 2024 | 52.19M |
| June 30, 2024 | 32.07M |
| December 31, 2023 | 20.34M |
| June 30, 2023 | 16.99M |
| December 31, 2022 | 16.33M |
| June 30, 2022 | 12.84M |
| December 31, 2021 | 13.51M |
| June 30, 2021 | 16.41M |
| December 31, 2020 | 15.47M |
| June 30, 2020 | 16.34M |
| December 31, 2019 | 16.97M |
| June 30, 2019 | 15.54M |
| December 31, 2018 | 12.27M |
| June 30, 2018 | 10.68M |
| December 31, 2017 | 10.22M |
| Date | Value |
|---|---|
| June 30, 2017 | 10.12M |
| December 31, 2016 | 9.124M |
| June 30, 2016 | 14.78M |
| December 31, 2015 | 25.62M |
| June 30, 2015 | 27.66M |
| December 31, 2014 | 25.49M |
| June 30, 2014 | 28.47M |
| December 31, 2013 | 23.46M |
| June 30, 2013 | 15.85M |
| December 31, 2012 | 14.00M |
| June 30, 2012 | 9.509M |
| December 31, 2011 | 7.192M |
| June 30, 2011 | 9.168M |
| December 31, 2010 | 8.971M |
| June 30, 2010 | 5.740M |
| December 31, 2009 | 6.140M |
| June 30, 2009 | 5.117M |
| December 31, 2008 | 6.425M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Avadel Pharmaceuticals Plc | 39.89M |
| Jazz Pharmaceuticals Plc | 815.61M |
| Perrigo Co. Plc | 95.00M |
| GH Research Plc | 46.71M |
| Alkermes Plc | 384.84M |